About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
IRWD - Ironwood Pharmaceuti...| Previous Close | $9.46 | Open | $9.49 |
| Volume | 899.6K | Market Cap | 1.709B |
| Yield | Last Dividend |
| Ironwood Pharmaceuticals to Participate ... | 09/02/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences... | |
| Ironwood Pharmaceuticals Reports Second ... | 08/06/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its second quarte... | |
| Ironwood Pharmaceuticals to Host Second ... | 07/23/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its second quarter 2020 investor update conference... | |
| Hedge Funds Still Bullish On Ironwood Ph... | 06/06/20 |
| The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that sho... | |
| Why Is Ironwood (IRWD) Down 3.6% Since L... | 06/05/20 |
| Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Ironwood Pharmaceuticals (IRWD) Looks Go... | 06/03/20 |
| Ironwood Pharmaceuticals (IRWD) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes. | |
| Ironwood (IRWD) Misses Q1 Earnings and R... | 05/07/20 |
| Ironwood (IRWD) witnesses strong demand for Linzess in the first quarter. COVID-19 impacts enrollment in clinical studies. | |
| Ironwood Pharmaceuticals (IRWD) Misses Q... | 05/06/20 |
| Ironwood (IRWD) delivered earnings and revenue surprises of -63.64% and -7.90%, respectively, for the quarter ended March 2020. Do the numbers hold cl... | |
| Ironwood Pharmaceuticals Reports First Q... | 05/06/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its first quarter... | |
| Ironwood and Allergan Receive Notices of... | 04/28/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the United States Patent and Trademark Office (USPTO) has ... | |
| Ironwood Pharmaceuticals to Host First Q... | 04/16/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2020 investor update conference ... | |
| Can Ironwood (IRWD) Keep the Earnings Su... | 04/16/20 |
| Ironwood (IRWD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat... | |
| Ironwood Pharmaceuticals Provides Update... | 03/26/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today provided an update on certain impacts o... | |
| Ironwood (IRWD) Down 22.1% Since Last Ea... | 03/14/20 |
| Ironwood (IRWD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Ironwood (IRWD) Surpasses Q4 Earnings an... | 02/14/20 |
| Ironwood (IRWD) witnesses strong demand for Linzess in the fourth quarter as well. Stock up. | |
| Ironwood Pharmaceuticals Reports Strong ... | 02/13/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its fourth quarte... | |
| What's in Store for Ironwood (IRWD) This... | 02/10/20 |
| Ironwood Pharmaceuticals' (IRWD) Linzess is likely to have driven total revenues in the fourth quarter. | |
| Ironwood Pharmaceuticals (IRWD) Earnings... | 02/06/20 |
| Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| Ironwood Pharmaceuticals to Host Fourth ... | 01/30/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its fourth quarter and full- year 2019 investor up... | |
| Ironwood/Allergan settle patent dispute ... | 01/22/20 |
| Ironwood Pharmaceuticals (IRWD +0.8%) and licensee Allergan (AGN) have settled patent infringement litigation with Teva Pharmaceutical Industries (TEV... | |
| Ironwood Pharmaceuticals to Present at J... | 01/02/20 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 38th Annual J.P. Morgan Healthcare Confe... | |
| 5 Reasons Why Ironwood Stock Should Be i... | 01/02/20 |
| We provide five reasons which makes Ironwood (IRWD) a good investment option in 2020. | |
| Is Ironwood Pharmaceuticals (IRWD) Outpe... | 12/25/19 |
| Is (IRWD) Outperforming Other Medical Stocks This Year? | |
| The Daily Biotech Pulse: Positive Adcom ... | 12/18/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 17) ... | |
| Ironwood Pharmaceuticals to Present at t... | 11/05/19 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 28th Annual Credit Suisse Healthcare Con... | |
| Ironwood (IRWD) Beats on Q3 Earnings & R... | 11/01/19 |
| Ironwood (IRWD) witnesses strong demand for Linzess in the third quarter as well. | |
| Ironwood Pharmaceuticals Reports Third Q... | 10/31/19 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided an update on its third quarter... | |
| Pear Therapeutics Announces Agreement wi... | 10/30/19 |
| BOSTON--(BUSINESS WIRE)--Pear Therapeutics, Inc. announced today that it has entered into an agreement with Ironwood Pharmaceuticals, Inc. to evaluate... | |
| Ironwood Pharmaceuticals to Highlight Ne... | 10/28/19 |
| BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced the presentation of clinical ... | |
| Ironwood Pharmaceuticals (IRWD) Reports ... | 10/24/19 |
| Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| Hold rating | 08/07/20 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $10.00 to $11.00 | |
| Hold rating | 07/15/20 |
| Morgan Stanley maintains Equal-Weight rating and lowers Price Target from $11.00 to $10.00 | |
| Date | 2020-08-06 (BMO) | Est. (EPS/Rev.) | $0.09/ 86.24M |
| Actual (EPS/Rev.) | $0.16/ $89.43 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
